Bailey Gregory's Form 4 filing
Serina Therapeutics, Inc.SER · filed Dec 19, 2024
- Accession no.
- 0001493152-24-050774
- Filed
- Dec 19, 2024
- Trade date
- Dec 17, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $17.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bailey GregoryCIK 0001329505 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 | Common Stock | PPurchaseAcquired | +3,866 | $4.59F1 | +$17,744.94 | 67,243 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reflects the weighted average purchase price of multiple transactions ranging from a low of $4.54 per share to a high of $4.74 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.
Referenced by the price of 1 transaction in Table I.